Consultant360Autonomous AI Increases Diabetic Retinopathy Screening Rates, Access For Young Patients

Autonomous AI technology at the point of care shows promise in improving screening rates for diabetic retinopathy among youth, potentially reducing care disparities in under-resourced communities.

A study led by Dr. Risa M. Wolf at Johns Hopkins University demonstrates that the use of autonomous artificial intelligence (AI) for diabetic retinopathy screening significantly increases completion rates among pediatric and adolescent patients compared to the current standard of care. The findings reveal practical implications for integrating AI-driven diagnostics in clinical practice to address access gaps and enhance care delivery for underserved populations.

Key Points:

• Study Background and Hypothesis:
  • Researchers at Johns Hopkins University aimed to evaluate whether autonomous AI diabetic eye exams at the point of care could improve screening rates and reduce access disparities for young patients.
  • The hypothesis was that autonomous AI would enhance screening completion rates compared to traditional methods.
• Study Design:
  • A randomized control trial was conducted, involving 164 participants who required a diabetic eye exam and had not had one in over six months.
  • Participants were randomized into two groups: autonomous AI diabetic eye exams at the point of care and the standard care group, which required scheduling and attending an eye doctor appointment.
• Initial Observational Study:
  • Prior to the randomized control trial, a prospective observational study with 310 children and adolescents showed an increase in screening rates from 49% to 95% using autonomous AI.
• Key Findings:
  • Screening Completion Rates:
    • 100% of participants in the AI group completed their diabetic eye exams during their regular clinic visits.
    • Only 22% of participants in the standard care group completed their diabetic eye exams within six months.
  • Surprising Outcomes:
    • The significant difference in completion rates between the AI and standard care groups exceeded researchers’ expectations.
  • Disparities in Screening:
    • The study highlighted existing disparities in screening rates, with minorities, lower-income households, and lower parental education levels less likely to have prior diabetic eye exams.
• Clinical Implications:
  • Autonomous AI screening at the point of care offers a practical solution to increase diabetic retinopathy screening rates among young patients.
  • Implementing AI-driven diagnostics can reduce the burden on patients and families, minimizing the need for additional appointments and associated costs.
  • The use of autonomous AI may help mitigate healthcare disparities by making screening more accessible to underserved populations.
• Future Research:
  • Ongoing studies aim to determine whether AI-driven screening can achieve equivalence in who gets screened and reduce disparities in screening rates.
  • Researchers are investigating whether early detection through AI can lead to better management of diabetic retinopathy and improved patient outcomes.

“As a pediatric endocrinologist, I think it is important for us to know that while we take care of children and adolescents and there may be low rates and prevalence of diabetic retinopathy in this population, recent large studies have shown that the prevalence is actually very significant after having a diabetes duration of 10 to 12 years, and we see that both for type 1 and type 2 diabetes.”
– Risa M. Wolf, MD, Pediatric Endocrinologist and the Director of Pediatric Diabetes Program at the Johns Hopkins Children’s Center in Baltimore, Maryland

More on Diabetic Eye Disease (DED)